Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles

Area of Science:

• Biochemistry
• Molecular Biology
• Nanotechnology

Background:

• High expression of multidrug resistance-associated protein 1 (MRP1) in tumor cells significantly reduces the effectiveness of chemotherapy drugs.
• Overcoming MRP1-mediated drug resistance is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To screen for multidrug resistance-associated protein 1 interfering RNA (MRP1-siRNA) molecules capable of reversing etoposide resistance in rat glioma cells.
• To evaluate the efficacy of chitosan-MRP1-siRNA nanoparticles in gene silencing and overcoming drug resistance.

Main Methods:

• Screening of MRP1-siRNA molecules to identify those that deplete MRP1 gene expression.
• Formulation and testing of chitosan-MRP1-siRNA nanoparticles for their silencing effect on MRP1 mRNA and protein.
• Assessment of etoposide resistance reversal in C6/VP16 glioma cells.

Main Results:

• Identification of a specific MRP1-siRNA molecule that effectively depletes MRP1 gene expression and reverses etoposide resistance.
• Chitosan-MRP1-siRNA nanoparticles, particularly at an N:P ratio of 175, demonstrated effective inhibition of MRP1 mRNA and protein expression.
• Chitosan was confirmed as a viable carrier for efficient siRNA delivery and gene silencing in tumor cells.

Conclusions:

• Chitosan-based nanoparticles are effective carriers for MRP1-siRNA delivery, enabling efficient gene silencing.
• This approach holds promise for overcoming multidrug resistance in cancer therapy by targeting MRP1.
• The developed chitosan-MRP1-siRNA nanoparticles represent a potential strategy for enhancing chemotherapy efficacy.